Anybody got a non paywalled link for our reading?
KKR & Co.’s Envision Healthcare Corp. is exploring a chapter 11 bankruptcy that would give control of the physician-staffing company to its creditors, according to people familiar with the matter.
Envision is in negotiations with some of its lenders about a restructuring that could result in KKR, its private-equity owner, writing down its stake, these people said. The staffing company has struggled with debt, litigation and other headwinds since KKR bought it in 2018 for roughly $6 billion, excluding debt, in one of the private-equity firm’s biggest healthcare deals.
Large creditors to Envision have been signing nondisclosure agreements to gain access to the company’s financial details and discuss a recapitalization, the people said. Some proposals include transactions where lenders would swap debt for equity, diluting or wiping out KKR’s equity stake in the process, they said.
Envision could file for chapter 11 protection as part of the recapitalization efforts, although it is possible that the company will be able to complete the transactions out-of- court and avoid filing for bankruptcy, the people familiar with the matter said.
The Nashville, Tenn.-based company missed a roughly $40 million interest payment due Saturday under some of its unsecured bonds, the people said, kicking off a grace period that could trigger a default if Envision fails to pay within 30 days.
Envision and KKR declined to comment.
Difficulties for the staffing company include a high debt burden and continuing regulatory pressures, according to an S&P Global Ratings report published last year. Envision’s business took a hit from declining emergency-room visits during the Covid-19 pandemic and the company has struggled with contract battles against UnitedHealth Group Inc. after it was cut out of the insurer’s network.
Envision faces around $700 million in annual cash interest expenses, according to the people familiar with the matter, who added that its outsourced-physician unit notched a roughly $40 million loss for the 12 months ended Sept. 30.
The company missed a March 31 deadline to report its fourth-quarter financial results, triggering a technical default under its loans, The Wall Street Journal previously reported.
One source of financial stress is an intercompany loan from Envision’s ambulatory- services unit, AmSurg Corp., to the core Envision business that comes due at the end of April, according to the people familiar. AmSurg made up roughly half the company’s total revenue as of 2021.
Last year, Envision raised more funds secured against AmSurg and managed to cut roughly $600 million in debt after moving its AmSurg assets out of some creditors’ reach to secure new loans.
Current trading prices of Envision’s debt securities imply that KKR’s stake in the company might be worthless, the people familiar with the matter said. Many of Envision’s bonds and loans are trading at less than 20 cents on the dollar, according to market-data platform Solve Advisors Inc., a sign that investors expect to get back only a fraction of what they invested in the company.